InvestorsHub Logo
Followers 2
Posts 107
Boards Moderated 0
Alias Born 10/15/2019

Re: dndodd post# 824

Tuesday, 11/16/2021 9:36:41 AM

Tuesday, November 16, 2021 9:36:41 AM

Post# of 1203
Don't you feel like the statement was to be expected? If they had FDA approval already they would have had to disclose, so they clearly didn't have it. The comment was;

"In parallel with advancing our commercial plan in Europe, we continue to engage actively with the FDA regarding the TAEUS system's 510(k) submission. We are working collaboratively with the Agency for agreement on a definitive path forward, including potentially providing additional real-world clinical data, as the review period has taken longer than we expected," stated Francois Michelon, Chairman and Chief Executive Officer of ENDRA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NDRA News